BASF stock: Company ends pursuit of Evonik takeover
Published on 11/21/2026 at 11:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSEvonik bid ends after rejections
- BASF ended its pursuit of Evonik on November 19 after two non-binding all-cash offers were rejected.
- The company said a higher valuation was not justified by Evonik's standalone prospects and associated risks.
- BASF is due to hold its Capital Markets Day on November 23 and 24.
BASF ended its pursuit of Evonik on November 19 after the specialty chemicals company rejected two non-binding all-cash offers. In a BASF news release, the group said Evonik's executive board had not shown meaningful engagement despite the possibility of a further moderate increase.
BASF said its assessment of Evonik as a standalone company and the associated risks did not justify a higher valuation. The company therefore concluded that continuing the transaction at a higher price would not serve shareholders' interests.
Capital discipline takes priority
The latest proposal valued Evonik at 24 euros per share. BASF said the combination could have created a stronger chemicals group, but described acquisitions as an option rather than a requirement under its Winning Ways strategy.
For investors, the decision removes a major potential transaction from BASF's strategic agenda while leaving the company's broader portfolio and shareholder-distribution priorities in focus. The announcement does not change BASF's existing operating segments, but it marks a clear limit on the price the group was prepared to pay for Evonik.
Next strategic milestone approaches
BASF is scheduled to hold its Capital Markets Day on November 23 and 24. The event could provide further detail on portfolio priorities, capital allocation and the company's approach to growth following the end of the Evonik effort.
BASF company facts
- Company: BASF SE
- ISIN: DE000BASF111
- Week event: End of the Evonik acquisition effort on November 19, 2026
- Latest offer: 24 euros per Evonik share
German equities remain part of a broader market setting tracked in Current market reports.
